CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
Francesco Lanza(Ospedale "Santa Maria delle Croci" di Ravenna), Fabio Malavasi(Fondazione Ricerca Molinette), Michela Rondoni(Azienda Unità Sanitaria Locale Della Romagna), Angelo Corso Faini(Fondazione Ricerca Molinette), Enrico Maffini(Istituto di Ematologia di Bologna), Evita Massari(Azienda Unità Sanitaria Locale Della Romagna)
Cited by 78
Related Papers
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
CD38 antibodies in multiple myeloma: back to the future
|Blood|2017|482
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
|Bone Marrow Transplantation|2015|337